Tweet
Los Angeles Times
<img alt="" height="1" width="1" />
Roche's Futile Fight For a Measurable Good
Wall Street Journal (blog)
Roche's infighting with the Food and Drug Administration may look futile but the Swiss giant's standoff with the US government over the future use of Avastin as a breast cancer treatment may still help the industry. ...
One patient's plea for FDA approval of AvastinReuters
Avastin for Breast Cancer: FDA Answer Is Still NoMedscape
FDA panel against use of Avastin for breast cancerSan Francisco Chronicle
ABC News -WebMD -CNN
all 1,077 news articles »
More...